Drug Trial Radar · NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
11,800
Planned (sponsor's estimate)
Start
Jul 22, 2025
Primary completion
Dec 14, 2029
Study completion Dec 21, 2029
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Jul 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin. Participants are put into 2 groups randomly, which means by chance. One group takes vicadrostat and empagliflozin tablets, and the other group takes placebo tablets with empagliflozin. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take a tablet once per day for 2 and a half years and up to 4 years and 3 months. All participants also continue their medication for type 2 diabetes, high blood pressure, and cardiovascular disease. Participants have an equal chance of receiving the study medicine or placebo. Participants are in the study for up to 4 years and 3 months. During this time, they visit the study site regularly. During these visits, doctors collect information about participants' health and take blood samples. The doctors document when participants experience cardiovascular events. The doctors also regularly check participants' health and take note of any unwanted effects.
Conditions
- Diabetes Mellitus, Type 2
- Hypertension
- Cardiovascular Diseases
Interventions
VicadrostatDrug
Vicadrostat
EmpagliflozinDrug
Empagliflozin
Placebo matching VicadrostatDrug
Placebo matching Vicadrostat
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first event of cardiovascular (CV) death or heart failure event (HFE)Time frame: Up to 51 months
Locations
1,142 sites in 51 countries. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama · Recruiting
Eastern Shore Research Group
Fairhope, Alabama · Recruiting
Lakeview Clinical Research
Guntersville, Alabama · Recruiting
Arizona Clinical Trials - Chandler
Chandler, Arizona · Recruiting
Elite Clinical Studies
Phoenix, Arizona · Recruiting
Clinical Research Institute of Arizona, LLC
Sun City West, Arizona · Recruiting
Fiel Family & Sports Medicine
Tempe, Arizona · Recruiting
Arizona Clinical Trials
Tucson, Arizona · Recruiting
Yuma Clinical Trials
Yuma, Arizona · Recruiting
National Heart Institute
Beverly Hills, California · Recruiting
Hope Clinical Research
Canoga Park, California · Recruiting
John Muir Physician Network Clinical Research Center
Concord, California · Recruiting
Velocity Clinical Research-Huntington Park
Huntington Park, California · Recruiting
Velocity Clinical Research, San Diego
La Mesa, California · Recruiting
First Valley Medical Group
Lancaster, California · Recruiting
ARK Clinical Research
Long Beach, California · Recruiting
Diabetes Associates Medical Group
Orange, California · Recruiting
Empire Clinical Research
Pomona, California · Recruiting
Velocity Clinical Research - San Bernardino
San Bernardino, California · Recruiting
Acclaim Clinical Research
San Diego, California · Recruiting
NorthBay Clinical Research, LLC
Santa Rosa, California · Recruiting
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California · Recruiting
Blue Coast Research Center, LLC
Vista, California · Recruiting
Rocky Mountain Regional VA Medical Center
Aurora, Colorado · Recruiting
OptumCare Clinical Trials, LLC
Golden, Colorado · Terminated
Cardiology Physicians of Fairfield County - Bridgeport
Bridgeport, Connecticut · Recruiting
CMR of Greater New Haven, LLC
Hamden, Connecticut · Recruiting
Cardiology Associates of Fairfield County
Stamford, Connecticut · Recruiting
Excel Medical Clinical Trials
Boca Raton, Florida · Recruiting
Clinical Research of West Florida, Inc.
Clearwater, Florida · Recruiting
Beautiful Minds Clinical Research Center
Cutler Bay, Florida · Recruiting
Hillcrest Medical Research
DeLand, Florida · Recruiting
University Clinical Research Deland, LLC
DeLand, Florida · Recruiting
Universal Axon Clinical Research
Doral, Florida · Recruiting
Northeast Research Institute
Fleming Island, Florida · Recruiting
Covenant Metabolic Specialists, LLC - Fort Myers
Fort Myers, Florida · Recruiting
Velocity Clinical Research-Hallandale Beach-67888
Hallandale, Florida · Recruiting
Northeast Research Institute
Jacksonville, Florida · Recruiting
Westside Center for Clinical Research
Jacksonville, Florida · Recruiting
East Coast Institute for Research, LLC - Southside
Jacksonville, Florida · Recruiting
Showing 40 of 1,142 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.